Alkermes
ALKSDublin, Ireland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profileMarket Cap: $7.5BPipeline: 92 drugs (35 Phase 3)Founded: 1987HQ: Dublin, Ireland
Overview
Alkermes plc is a fully integrated, global biopharmaceutical company headquartered in Dublin, Ireland with significant U.S. operations, specializing in the discovery, development, and commercialization of innovative medicines for complex psychiatric and neurological disorders. The company applies deep neuroscience expertise to address traditionally overlooked therapeutic areas including addiction, serious mental illness, and sleep disorders, operating with a patient-inspired approach across the entire value chain from discovery through manufacturing and commercialization.
Small Molecules
Pipeline
9292 drugs in pipeline35 in Phase 3
| Drug | Indication | Stage | Watch |
|---|---|---|---|
| Naltrexone for extended-release injectable suspension + Oral... | Opioid-Related Disorders | Approved | |
| XR-NTX 380 mg, intramuscular injection + Placebo intramuscul... | Alcohol Use Disorder | Approved | |
| Aripiprazole Lauroxil | Schizophrenia | Approved | |
| VIVITROL 380 mg + Placebo | Alcohol Dependence | Approved | |
| Aripiprazole Lauroxil | Schizophrenia | Approved |